Medication Cost Is the #1 Barrier to Adherence — and Bonjesta Is a Prime Example

You prescribed Bonjesta because your patient's morning sickness didn't respond to conservative management. The clinical decision was straightforward. But then your patient calls from the pharmacy: "They said it's $490. I can't afford that."

This scenario plays out daily across OB/GYN practices. Bonjesta is clinically effective, FDA-approved, and well-studied in pregnancy — but its $481–$490 cash price for 30 tablets creates a real barrier to adherence. When patients can't afford their medication, they skip doses, switch to less-studied alternatives, or simply go untreated.

The good news: there are multiple programs that can dramatically reduce or even eliminate the cost burden. This guide walks you through every available savings option so you can help your patients access the medication they need.

What Your Patients Are Actually Paying

Understanding the cost landscape helps you guide conversations effectively:

• Cash price (no insurance): $481–$490 for 30 tablets
• With commercial insurance (no copay card): Varies widely — some plans cover it after prior authorization, others require step therapy through generic doxylamine/pyridoxine or Diclegis first. Copays can range from $50 to $200+.
• With Bonjesta CoPay Savings Card: As low as $35–$40 for commercially insured patients
• Bonjesta At Home (uninsured): $60 for 30 tablets or $99 for 60 tablets with free home delivery
• Medicaid: Coverage varies by state. Some state Medicaid programs cover Bonjesta; others do not or require prior authorization.

The gap between the cash price and available savings programs is enormous — but only if patients and providers know these programs exist.

Manufacturer Savings Programs

Duchesnay USA offers two primary savings pathways:

Bonjesta CoPay Savings Card

For commercially insured patients:

• Eligible patients may pay as little as $35–$40 per prescription
• Covers the difference between the patient's copay and the program's cap
• Not available for patients on government insurance (Medicare, Medicaid, Tricare, VA)
• Patients can enroll at bonjesta.com/bonjesta-savings or by calling 1-800-835-0755

Clinical workflow tip: Have your front desk or MA mention the copay card when sending the prescription. Better yet, include the enrollment link or phone number on a printed handout given at the time of prescribing. Patients are most likely to follow through when the information is in their hands before they reach the pharmacy counter.

Bonjesta At Home (Mail-Order Program)

For uninsured patients or those whose insurance doesn't cover Bonjesta:

• $60 for 30 tablets or $99 for 60 tablets
• Free home delivery — medication ships directly to the patient
• Access to on-staff pharmacists for questions
• Enrollment: call 1-800-835-0755 or visit bonjesta.com/bonjesta-savings

This program is a game-changer for uninsured patients. The $60 price point is competitive with — or cheaper than — many generic alternatives, and the home delivery eliminates the pharmacy availability problem entirely.

Clinical workflow tip: For uninsured patients, consider recommending Bonjesta At Home as the default fulfillment pathway. It bypasses insurance headaches, pharmacy stocking issues, and delivers predictable pricing.

Coupon and Discount Card Options

Beyond the manufacturer programs, several third-party discount platforms may offer Bonjesta savings:

• GoodRx — Shows prices at nearby pharmacies and sometimes offers coupons. However, for brand-name Bonjesta, GoodRx prices are often close to the full cash price ($480+) unless a specific promotion is running.
• SingleCare — Similar to GoodRx; may show slightly different prices depending on the pharmacy.
• RxSaver, Optum Perks, BuzzRx — Additional coupon platforms worth checking, though savings on brand-name-only medications are typically limited.

Important note: For most patients, the manufacturer programs (copay card or At Home) will offer significantly better pricing than third-party coupon cards. Steer patients to the manufacturer programs first.

Generic Alternatives and Therapeutic Substitution

When cost is the primary barrier and the manufacturer programs aren't an option, consider these therapeutic alternatives:

Generic Doxylamine/Pyridoxine (Generic Diclegis)

• Same active ingredients as Bonjesta (doxylamine succinate + pyridoxine hydrochloride)
• Lower-strength delayed-release formulation: 10 mg/10 mg per tablet (vs. Bonjesta's 20 mg/20 mg)
• Requires up to 4 tablets daily (vs. 1–2 with Bonjesta)
• Cash price: approximately $30–$80 for 60 tablets
• Better insurance coverage since generics are preferred on most formularies

The trade-off: more pills per day and delayed-release only (no immediate-release component). For patients who were specifically struggling with the convenience or onset speed of Bonjesta, this may not be ideal. But for cost-sensitive patients, it's the most clinically comparable option.

Ondansetron (Generic Zofran)

• Serotonin 5-HT3 receptor antagonist — different mechanism of action
• Used off-label for pregnancy nausea
• Very inexpensive as a generic: typically $10–$30
• Does not cause drowsiness
• Not specifically FDA-approved for NVP

OTC Vitamin B6 + Doxylamine (Unisom SleepTabs)

• The "DIY" version — same active ingredients purchased separately
• Total cost: under $20
• No extended-release technology
• Dosing is less precise, but ACOG recommends this as a first-line approach

For a comprehensive comparison of all alternatives, see our alternatives guide.

Building Cost Conversations Into Your Workflow

The most effective savings program in the world doesn't help if patients don't know about it. Here's how to integrate cost awareness into your practice:

At the Point of Prescribing

• Proactively mention cost. Don't wait for the patient to bring it up. A simple "Bonjesta can be expensive without the savings programs — let me make sure you have the information" goes a long way.
• Hand them the information. Print a one-page handout with the copay card enrollment link, Bonjesta At Home phone number (1-800-835-0755), and what to expect at the pharmacy. Patients who receive written materials are significantly more likely to follow through.
• Document the conversation. Note in the chart that savings programs were discussed. This also supports prior authorization requests.

Prior Authorization Strategy

Many insurers require step therapy before covering Bonjesta. Be prepared to document:

• That the patient has tried and failed conservative management
• That generic doxylamine/pyridoxine or Diclegis was tried if step therapy is required
• The clinical rationale for Bonjesta specifically (e.g., adherence concerns with 4-tablet-daily regimen, need for immediate-release component)

Some practices designate a staff member to handle prior authorizations for specialty medications. If you prescribe Bonjesta regularly, this can significantly reduce the administrative burden.

Follow-Up

• At the next visit, ask: "Were you able to fill the Bonjesta prescription? Did the savings program work?"
• If there were issues, troubleshoot. Common problems include the pharmacy not running the copay card correctly, insurance denying coverage without PA, or the patient not knowing about At Home.
• Track patterns — if a specific insurer consistently denies Bonjesta, adjust your approach (e.g., start with generic Diclegis and escalate to Bonjesta if needed).

Resources for Your Practice

• Medfinder for Providers: medfinder.com/providers — tools to help your patients find pharmacies with Bonjesta in stock
• Bonjesta Savings: bonjesta.com/bonjesta-savings — copay card and At Home enrollment
• Duchesnay Medical Information: 1-800-835-0755 — for clinical questions or patient support

Final Thoughts

Bonjesta works. The clinical evidence is clear, and the FDA approval speaks for itself. But a $490 medication that a patient can't afford is the same as no medication at all.

By knowing the savings landscape and building cost conversations into your workflow, you can help ensure that the right patients get the right medication — without the financial barrier. The Bonjesta CoPay Savings Card ($35–$40 for insured patients) and At Home program ($60 for uninsured patients) make this medication genuinely accessible for most women.

For tools to help your patients find Bonjesta in stock and navigate the healthcare system, visit Medfinder for Providers.